Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China
Thursday, July 11, 2019MacroGenics Inc a clinicalstage biopharmaceutical company focused on discovering and developing innovative monoclonal antibodybased therapeutics for the treatment of cancer and IMab Biopharma IMab a China and USbased clinicalstage biopharmaceutical c...
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
Thursday, July 11, 2019Altimmune Inc a clinicalstage biopharmaceutical company today announced that it has entered into an agreement to acquire Spitfire Pharma Inc Spitfire including its product candidate SP to be renamed ALT a potent GLPGlucagon receptor coagonist for the...
Mirati Announces Clinical Collaboration to Evaluate MRTX849 in Combination with SHP2 Inhibitor TNO155
Wednesday, July 10, 2019Mirati Therapeutics Inc a clinicalstage targeted oncology company today announced a clinical collaboration agreement with Novartis to evaluate the combination of MRTX Miratis investigational KRAS GC inhibitor and TNO Novartis investigational SHP inhi...
ImaginAb Announces Collaboration on CD8 Imaging Agent with Roche
Wednesday, July 10, 2019ImaginAb Inc a clinical stage immunooncology imaging company announced today that it has entered into a nonexclusive license and collaboration agreement with Roche Under the terms of the agreement Roche will use ImaginAbs novel minibody CD T cell ima...
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics
Tuesday, July 09, 2019Lyndra Therapeutics the company making daily pills a thing of the past has announced a partnership with Gilead Sciences Inc to develop and commercialize ultralongacting oral HIV therapies Gilead will have exclusive rights to Lyndras therapeutics plat...
Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol® License and Supply Agreements for High-Concentration Furosemide Formulation
Tuesday, July 09, 2019Ligand Pharmaceuticals Incorporated NASDAQ LGND and SQ Innovation AG today announced that the two companies have entered into longterm exclusive commercial license and supply agreements for use of Ligands Captisol technology in the formulation of hig...
Priority Review Granted to BeiGene’s Supplemental New Drug Application in China for Tislelizumab in Urothelial Carcinoma
Monday, July 08, 2019BeiGene Ltd a commercialstage biopharmaceutical company focused on developing and commercializing innovative molecularlytargeted and immunooncology drugs for the treatment of cancer today announced that the China National Medical Products Administrat...
Cyxone Submits First Application to Start Clinical Phase IIb Trial With Rabeximod
Saturday, July 06, 2019Cyxone publ a Swedish biotech in autoimmune diseases today submitted an application to the Central Ethics Committee CEC in Poland for permission to start a clinical phase IIb trial with its drug candidate Rabeximod which is in development for the tre...
China SXT Pharmaceuticals, Inc. Announces TCM Homologous Supplements Production
Thursday, July 04, 2019China SXT Pharmaceuticals Inc a specialty pharmaceutical company focusing on the research development manufacture marketing and sales of Traditional Chinese Medicine Pieces TCMPs today announced that it has begun the production of TCM Homologous Supp...
Asieris and Photocure Enter into a License Agreement for World-Wide Development and Commercialization of Cevira®
Wednesday, July 03, 2019Asieris MediTech Co Ltd a Chinabased biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases and Photocure ASA Photocure PHO OSE The Bladder Cancer Company anno...
